K. Boelaert, P.R. Newby, M.J. Simmonds, R.L. Holder, J.D. Carr-Smith, J.M. Heward, N. Manji, A. Allahabadia, M. Armitage, K.V. Chatterjee, J.H. Lazarus, S.H. Pearce, B. Vaidya, S.C. Gough, J.A. Franklyn, Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am. J. Med. 123, 183.e1–9 (2010)
H.H. Tseng, Y.B. Lin, K.Y. Lin, C.H. Lin, H.Y. Li, C.H. Chang, Y.C. Tung, P.L. Chen, C.Y. Wang, W.S. Yang, S.R. Shih, A 20-year study of autoimmune polyendocrine syndrome type II and III in Taiwan. Eur. Thyroid J. 12, e230162 (2023)
Article PubMed PubMed Central Google Scholar
S.M. Ferrari, P. Fallahi, I. Ruffilli, G. Elia, F. Ragusa, S. Benvenga, A. Antonelli, The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): Review of the literature and report of a large series. Autoimmun. Rev. 18, 287–292 (2019)
E.S. Husebye, M.S. Anderson, O. Kämpe, Autoimmune Polyendocrine Syndromes. N. Engl. J. Med. 378, 1132–1141 (2018)
Article PubMed PubMed Central Google Scholar
J. Wang, K. Wan, X. Chang, R.F. Mao, Association of autoimmune thyroid disease with type 1 diabetes mellitus and its ultrasonic diagnosis and management. World J. Diab. 15, 348–360 (2024)
F. De Luca, A. Corrias, M. Salerno, M. Wasniewska, R. Gastaldi, A. Cassio, A. Mussa, T. Aversa, G. Radetti, T. Arrigo, Peculiarities of Graves’ disease in children and adolescents with Down’s syndrome. Eur. J. Endocrinol. 162, 591–595 (2010)
M. Valenzise, T. Aversa, A. Corrias, L. Mazzanti, M. Cappa, G. Ubertini, E. Scarano, A. Mussa, M.F. Messina, F. De Luca, M. Wisniewski, Epidemiology, presentation and long-term evolution of Graves' disease in children, adolescents and young adults with Turner syndrome. Horm. Res. Paediatr. 81, 245–250 (2014)
M. Rotondi, C. Virili, S. Pinto, F. Coperchini, L. Croce, N. Brusca, M. Centanni, L. Chiovato, The clinical phenotype of Graves' disease occurring as an isolated condition or in association with other autoimmune diseases. J. Endocrinol. Invest. 43, 157–162 (2020)
M. Neufeld, N. Maclaren, R. Blizzard, Autoimmune polyglandular syndromes. Pediatr. Ann. 9, 154–162 (1980)
National Health Commission's Expert Committee on Endemic Diseases Standards. Diagnostic criteria for endemic goiter: WS 276-2007. Beijing: Ministry of Health of the People’s Republic of China (2007)
C.F. Mooij, T.D. Cheetham, F.A. Verburg, A. Eckstein, S.H. Pearce, J. Léger, A. van Trotsenburg, 2022 European Thyroid Association Guideline for the management of pediatric Graves’ disease. Eur. Thyroid J. 11, e210073 (2022)
H. Li, C.Y. Ji, X.N. Zong, Y.Q. Zhang, Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years. Zhonghua Er Ke Za Zhi 47, 487–492 (2009)
E. Atallah, C. Freixo, I. Alvarez-Alvarez, F.J. Cubero, A.L. Gerbes, G.A. Kullak-Ublick, G.P. Aithal, Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review. Expert Opin. Drug Metab. Toxicol. 17, 1327–1343 (2021)
C. Nederstigt, B.S. Uitbeijerse, L. Janssen, E. Corssmit, E. de Koning, O.M. Dekkers, Associated auto-immune disease in type 1 diabetes patients: a systematic review and meta-analysis. Eur. J. Endocrinol. 180, 135–144 (2019)
L.T. Wang, C.Y. Huang, C.H. Lin, B.W. Cheng, F.S. Lo, W.H. Ting, Y.J. Lee, Graves disease is more prevalent than Hashimoto disease in children and adolescents with type 1 diabetes. Front. Endocrinol. (Lausanne) 13, 1083690 (2022)
H. Payami, S. Joe, G. Thomson, Autoimmune thyroid disease in type I diabetic families. Genet. Epidemiol. 6, 137–141 (1989)
Society CD, Chinese Endocrinologist Association CSoE, Society CP, Guidelines for the diagnosis and treatment of type 1 diabetes mellitus in China (2021 edition). Chin. J. Diab. Mellit. 14, 1143–1250 (2022)
B. Biondi, G.J. Kahaly, R.P. Robertson, Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders. Endocr. Rev. 40, 789–824 (2019)
Article PubMed PubMed Central Google Scholar
Y.S. Eom, J.R. Wilson, V.J. Bernet, Links between Thyroid Disorders and Glucose Homeostasis. Diab. Metab. J. 46, 239–256 (2022)
F. Azizi, A. Amouzegar, D. Khalili, H. Abdi, M. Tohidi, M. Hedayati, L. Cheraghi, Y. Mehrabi, M. Takyar, Risk of recurrence at the time of withdrawal of short- or long-term methimazole therapy in patients with Graves’ hyperthyroidism: a randomized trial and a risk-scoring model. Endocrine 84, 577–588 (2024)
G. Barbesino, Y. Tomer, Clinical review: Clinical utility of TSH receptor antibodies. J. Clin. Endocrinol. Metab. 98, 2247–2255 (2013)
Article PubMed PubMed Central Google Scholar
D. Puttawong, P. Mahachoklertwattana, P. Numthavaj, P. Woratanarat, S. Pongratanakul, P. Koad, P. Poomthavorn, Long-term outcomes of anti-thyroid drug treatment in childhood-onset Graves’ disease. Clin. Endocrinol. (Oxf.) 98, 823–831 (2023)
K.B.S. Okamura, M.S.K. Fujikawa, H.K.T. Ikenoue, Long-Term Antithyroid Drug Treatment: Trends in Serum TSH and TSH Receptor Antibody Changes in Patients with Graves’ Disease. Int J. Endocrinol. Metab. 18, e101139 (2020)
M. Singh, S. Wambua, S.I. Lee, K. Okoth, Z. Wang, F. Fayaz, K.A. Eastwood, C. Nelson-Piercy, J.A. Reynolds, K. Nirantharakumar, F. Crowe, Autoimmune diseases and adverse pregnancy outcomes: an umbrella review. BMC Med. 22, 94 (2024)
Article PubMed PubMed Central Google Scholar
S.L. Thomas, C. Griffiths, L. Smeeth, C. Rooney, A.J. Hall, Burden of mortality associated with autoimmune diseases among females in the United Kingdom. Am. J. Public Health 100, 2279–2287 (2010)
留言 (0)